ISN Webinar: Advancements in C3 Glomerulopathy (C3G)

This webinar will provide a comprehensive view of C3 Glomerulopathy (C3G). It will first discuss the complexities of C3G, including classification (dense deposit disease vs. C3 glomerulonephritis), natural history, and biopsy. It will then cover the latest clinical trial data before discussing how new therapeutic agents will fit into the treatment landscape. 

Learning objectives:

- Provide an overview of C3G including classification, natural history and biopsy
- Explore the latest clinical trial data
- Consider how new agents will fit into the treatment landscape 

This webinar is supported by Novartis.